KFBIO

KFBIO was established in Aug, 2011. KFBIO was founded by a team with members all back from Japan. We are an innovative high-tech company specialized in digital pathology scanner manufacturing and AI powered pathology database research, we offer solutions for digital pathology remote diagnosis, pathology research and pathology education.

History of KFBIO

2020, Achieved B round financing (Intel Capital lead investment）
2019, Obtained the medical device registration certificate for Cervical Canner and TB AI Screening System
2018, Certificated by EN ISO 13485:  2016 System
2014, KFBIO high-precision slide scanner got CE Certificate

What’s our advantage ?

1, No 1 market share for digital pathology scanner in China (more than 40%) .
1500, more than 1500 KFBIO devices operating worldwide everyday .
67%, Proportion of R&D staff in the Team.
245, Software and Hardware Patents
175, Remote Pathology Diagnostic Platforms.